Cardiac risk evaluation for abdominal transplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 3, 2010, Pages 363-367

  Findlay, James Y ^a   Wen, Di ^b   Mandell, Mercedes S ^c  

^a MAYO CLINIC   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiomyopathy; Ischemic heart disease; Kidney transplantation; Liver transplantation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ANGIOCARDIOGRAPHY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EXERCISE TEST; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MYOCARDIAL PERFUSION IMAGING; NON INVASIVE MEASUREMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; SURGICAL RISK;

HEART DISEASES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVER DISEASES; LIVER TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77953292167     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328338a986     Document Type: Review

References (34)

1. Aalten J, Hoogeveen EK, Roodnat JI, et al. Associations between prekidneytransplant risk factors and posttransplant cardiovascular events and death. Transpl Int 2008; 21:985-991.
2. Boschiero L, Fior F, Nacchia F. Bimodal distribution of major cardiovascular events in kidney allograft recipients. Transplant Proc 2009; 41:1183-1186.
3. Leonardi G, Tamagnone M, Ferro M, et al. Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases. Clin Transplant 2009; 23:653-659.
4. Kumar N, Dahri L, Brown W, et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:1907-1913.
5. Issa N, Krowka MJ, Griffin MD, et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008; 86:1384-1388.
6. Hickson LJ, Cosio FG, El-Zoghby ZM, et al. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant 2008; 8:2352-2359.
7. Hickson LT, El-Zoghby ZM, Lorenz EC, et al. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant 2009; 9:1354-1361.
8. Oterdoom LH, de Vries AP, van Ree RM, et al. N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population. Transplantation 2009; 87:1562-1570.
9. Lentine KL, Schnitzler MA, Brennan DC, et al. Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol 2008; 3:1115-1124.
10. Patel RK, Mark PB, Johnston N, et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant 2008; 8:1673-1683.
11. Harinstein ME, Flaherty JD, Ansari AH, et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. Am J Transplant 2008; 8:1523-1528.
12. Zoghbi GJ, Patel AD, Ershadi RE, et al. Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation. Am J Cardiol 2003; 92:1066-1071.
13. Plotkin JS, Scott VL, Pinna A, et al. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2:426-430.
14. Diedrich DA, Findlay JY, Harrison BA, Rosen CB. Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc 2008; 40:3554-3557.
15. Tiukinhoy-Laing SD, Rossi JS, Bayram M, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol 2006; 98:178-181.
16. Filì D, Vizzini G, Biondo D, et al. Clinical burden of screening asymptomatic patients for coronary artery disease prior to liver transplantation. Am J Transplant 2009; 9:1151-1157.
17. Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009; 120:1189-1194.
18. Kadayifci A, Tan V, Ursell PC, et al. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. J Hepatol 2008; 49:595-599.
19. Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59:859-864.
20. Loong CY, Anagnostopoulos C. Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging. Heart 2004; 90 (Suppl 5):v2-v9. (Pubitemid 38998268)
21. Geleijnse ML, Krenning BJ, Nemes A, et al. Diagnostic value of dobutamine stress echocardiography in patients with normal wall motion at rest. Echocardiography 2007; 24:553-557.
22. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004; 110:835-842.
23. Davidson CJ, Gheorghiade M, Flaherty JD, et al. Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol 2002; 89:359-360.
24. Sharma M, Yong C, Majure D, et al. Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol 2009; 103:742-746.
25. Senzolo M, Bassanello M, Graziotto A, et al. Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation. Transplant Proc 2008; 40:1916-1917.
26. Umphrey LG, Hurst RT, Eleid MF, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl 2008; 14:886-892.
27. Fouad TR, Abdel-Razek WM, Burak KW, et al. Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87:763-770.
28. Shichi D, Matsumori A, Naruse TK, et al. HLA-DPbeta chain may confer the susceptibility to hepatitis C virus-associated hypertrophic cardiomyopathy. Int J Immunogenet 2008; 35:37-43.
29. Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009; 3:294-304.
30. Wong F, Girgrah N, Graba J, et al. The cardiac response to exercise in cirrhosis. Gut 2001; 49:268-275.
31. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009; 104:2458-2466.
32. Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut 2007; 56:869-875.
33. Bal JS, Thuluvath PJ. Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int 2003; 23:243-248.
34. Torregrosa M, Aguade S, Dos L, et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol 2005; 42:68-74.